Antiplatelet activity of inositol hexaphosphate (IP6)

Anticancer Research

Volumn 19, Issue 5 A, 1999, Pages 3689-3693

  Vucenik, Ivana ^a   Podczasy, John J ^a,b   Shamsuddin, Abulkalam M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Pasteur Merieux Connaught   (United States)

Author keywords

Atherosclerosis; Phytate; Thrombosis

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTITHROMBOCYTIC AGENT; COLLAGEN; PHYTIC ACID;

CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION; VOLUNTEER;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; HUMANS; PHYTIC ACID; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS;

EID: 0032778163     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Humble C: The evolving epidemiology of fiber and heart disease. Adv Exp Med Biol 427: 15-26, 1997.
2. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ and Willett WC: Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 275: 447-451, 1996.
3. Bagger M, Andersen O, Nielsen JB and Ryttig KR: Dietary fiber reduces blood pressure, serum total cholesterol and platelet aggregation in rats. British J Nutr 75: 483-493, 1996.
4. Gondal JA, MacArthy P, Myers AK and Preuss HG: Effect of dietary sucrose and fibers on blood pressure in hypertensive rats. Clin Nephrol 45: 163-168, 1996.
5. Wang C, Zhao L and Chen Y: Hypolipidemic action of soy fiber and its effects on platelet aggregation and coagulation time in rats. Chung Hua Yu Fang I Hsueh Tsa Chih 30: 205-208, 1996.
6. Conti CR and Mehta JL: Acute myocardial ischemla: Role of atherosclerosis, thrombosis, platelet activation, coronary vasospasm, and altered arachidonic acid metabolism. Circulation 75 Suppl 75 Suppl V: 84-95, 1987.
7. Farstad M: The role of blood platelets in coronary atherosclerosis and thrombosis. Scand J Clin Lab Invest 58: 1-10, 1998.
8. Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML. Becker RC, Hechtman HB and Michelson AD: Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 31: 352-358, 1998.
9. 6: A novel anticancer agent. Life Sciences 61: 343-354, 1997.
10. Vucenik I, Guang-yu Y and Shamsuddin AM: Comparison of pure inositol hexaphosphate and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis. Nutr Cancer 28: 7-13, 1997.
11. Jariwalla RJ, Sabin R. Lawson S and Herman ZS: Lowering of serum cholesterol and triglycerides and modulations by dietary phylate. J Appl Nutr 42: 18-28, 1990.
12. 6) reduces risk for cancer and cardiovascular diseases. Period Biol 99: 25-30, 1997.
13. Podczasy JJ, Lee J and Vucenik I: Evaluation of whole-blood lumiaggregation. Clin Appl Thrombosis/Hemostasis 3: 190-195, 1997.
14. Vucenik I and Podczasy JJ: Whole blood lumiaggregation: Evaluation of reagents. Clin Appl Thrombosis/Hemostasis 4: 453-256, 1998.
15. Blockmans D, Deckmyn H and Vermylen J: Platelet activation. Blood Rev 9: 143-156, 1995.
16. Murphy CT, Elmore M, Kellie S and Westwick J: The relationship between cytosolic calcium, sn-1,2-diacylglycerol and 1,4,5-trisphosphate elevation in platelet activating factor-stimulated rabbit platelets: influence of protein kinase C on production of signal molecules. Biochem J 278: 255-261, 1991.
17. Daniel JL, Dangelmaier CA and Smith JB: Formation and metabolism of inositol 1,4,5-risphosphate in human platelets. Biochem J 246: 109-114, 1987.
18. Puri RN and Colman RW: ADP-induced platelet activation. Crit Rev Biochem Mol Biol 32: 437-502, 1997.
19. Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB and Kunapuli SP: Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 273: 2024-2029, 1998.
20. Schwartz MA: Transmembrane signalling by integrins. Trends Cell Biol 2: 304-307, 1992.
21. Furman MI, Grigoryev D, Bray PF, Disc KR and Goldschmidt-Clermont Platelet tyrosine kinases and fibrinogen receptor activation. Circ Res 75: 172-180, 1994.
22. 3 exposure. Arterioscler Thromb Vasc Biol 18: 404-414, 1998.
23. Rittenhouse SE: Regulation of phosphatidylinositide 3-kinase, a potential signaling enzyme in platelets. Sem Hematol 32: 120-125, 1995.
24. Banfic H, Tang X, Batty IH, Downes CP, Chen C and Rittenhouse SE: A novel integrin-activated pathway forms PKB/Akt-stimulatory phosphatidylinositol 3,4-bisphosphate via phosphatidylinositol 3-phosphate in platelets. J Biol Chem 27: 13-16, 1998
25. 6): An antagonist of fibroblast growth factor receptor binding and activity. In vitro Cell Dev Biol 30A: 783-789, 1994.
26. 6) and insulin-like growth factor II receptor binding sites in the brain. Neuroreport 5: 625-628, 1994.
27. Huang C, Ma W-Y, Hecht SS and Dong Z: Inositol hexaphosphate inhibits cell transformation and activator protein I activation by targeting phosphatidylinositol-3 kinase. Cancer Res 57: 2873-2878, 1997.
28. 2+-mediated exocytosis of insulin by activation of protein kinase C. Proc Natl Acad Sci USA 94: 4435-4439, 1997.
29. 2+ channel activity by inositol hexakisphosphate. Science 278; 471-474, 1997.
30. Chronos N, Vahanian A, Betriu A, Emanuelsson H, Goldberg S, Gulba D and van Hout BA: Use of abciximab in interventional cardiology. Eur Heart J 19: D31-D39, 1998.
31. Choussat R and Montalescot G: Blocking platelets more: are we skating on thin ice? Heart 79: 5-6, 1998.
32. Minuz P, Lechi C, Tommasoli R, Gaino S, Degan M, Zuliani V, Bonapace S, Benoni G, Adami A, Cuzzolin I, and Lechi A: Anti-aggregating and vasodilatory effect of a new nitroderivative of acetylsalicylic acid. Throm Res 80: 367-376, 1995.